Synthesis of 8H-3a-Aza-cyclopenta[a]indenes and 5,10-Dihydropyrrolo[1,2-b]isoquinolines Derivatives and Their Use as Antitumor Therapeutic Agents
Docket Number:12A-960809
Inventor:Tsann-Long Su, Ting-Chao Chou
IP Status:Issued US8,410,130、TW368619
Abstract:
Our newly synthesized compounds are novel DNA dialkylating agents and have potential for therapeutic applications. They possess potent antitumor therapeutic effects with low toxicity to the host. These compounds have little or no cross-resistance to either Taxol or Vinblastine. In addition, the syntheses of these agents in large quantity have been established.
Fields of Application:
Cancer Chemotherapy.
Advantages when compared to the existing technologies:
- The newly invented compounds exhibits potent therapeutic efficacy in nude mice bearing human tumor xenografts with low toxicity.
- Complete tumor remission was observed when nude mice bearing human breast carcinoma MX-1 xenograft were treated with newly synthesized compounds.
- No cross-resistance to Taxol and Vinblastine.
- These agents can be prepared in large-scale.
Contact Person:Mei-Fang Lee / 886-2-2787-2503 / mflee@gate.sinica.edu.tw
IP Status:Issued US8410130、TW368619
